Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Affiliations

• ¹ John F. Hardesty, MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
• ² Department of Medicine and RVCL Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
• ³ Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
• ⁴ Departments of Medicine and Microbiology, Colton Center for Autoimmunity, and RVCL Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
• ⁵ Department of Medicine, Washington University, St. Louis, Missouri, USA.